PROCYON CORP
10KSB, EX-27, 2000-09-28
PHARMACEUTICAL PREPARATIONS
Previous: PROCYON CORP, 10KSB, 2000-09-28
Next: KOMAG INC /DE/, 10-K/A, 2000-09-28



<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1

<S>                                        <C>
<PERIOD-TYPE>                                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         479,334
<SECURITIES>                                         0
<RECEIVABLES>                                   17,189
<ALLOWANCES>                                       500
<INVENTORY>                                     59,066
<CURRENT-ASSETS>                               576,663
<PP&E>                                          49,029
<DEPRECIATION>                                  26,323
<TOTAL-ASSETS>                                 610,542
<CURRENT-LIABILITIES>                          109,614
<BONDS>                                              0
                                0
                                    368,133
<COMMON>                                     7,760,805
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   610,542
<SALES>                                        702,855
<TOTAL-REVENUES>                               702,855
<CGS>                                          134,026
<TOTAL-COSTS>                                  877,849
<OTHER-EXPENSES>                                 8,985
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,932
<INCOME-PRETAX>                               (318,005)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (318,005)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (318,005)
<EPS-BASIC>                                       (.08)
<EPS-DILUTED>                                     (.08)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission